Japan To Rule On Iressa Deaths; Government Cleared
This article was originally published in PharmAsia News
Executive Summary
Japan's Supreme Court agreed to consider an appeal brought by families seeking damages from AstraZeneca KK, which imported the Iressa (gefitinib) lung cancer drug from its parent, the UK's AstraZeneca.